MicroBase Technology Valuation
Is 3184 undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score 1/6
Price-To-Sales vs Peers
Price-To-Sales vs Industry
Price-To-Sales vs Fair Ratio
Below Fair Value
Significantly Below Fair Value
Key Valuation Metric
Which metric is best to use when looking at relative valuation for 3184?
Other financial metrics that can be useful for relative valuation.
|What is 3184's n/a Ratio?|
Price to Sales Ratio vs Peers
How does 3184's PS Ratio compare to its peers?
|Company||PS||Estimated Growth||Market Cap|
6815 Diamond Biotechnology
4188 AmCad BioMed
4744 CVC Technologies
3184 MicroBase Technology
Price-To-Sales vs Peers: 3184 is good value based on its Price-To-Sales Ratio (4.6x) compared to the peer average (4.7x).
Price to Earnings Ratio vs Industry
How does 3184's PE Ratio compare vs other companies in the TW Medical Equipment Industry?
Price to Sales Ratio vs Fair Ratio
What is 3184's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
|Current PS Ratio||4.6x|
|Fair PS Ratio||n/a|
Price-To-Sales vs Fair Ratio: Insufficient data to calculate 3184's Price-To-Sales Fair Ratio for valuation analysis.
Share Price vs Fair Value
What is the Fair Price of 3184 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: 3184 (NT$10.45) is trading above our estimate of fair value (NT$2.88)
Significantly Below Fair Value: 3184 is trading above our estimate of fair value.
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
Analyst Forecast: Insufficient data to show price forecast.